Skip to main content

Yeaman Kevin J's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Feb 15, 2023

Accession no.
0001209191-23-009875
Filed
Feb 15, 2023
Trade date
Feb 13-14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.57M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yeaman Kevin JCIK 0001200469Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 14, 2023Class A Common StockMOption exerciseAcquired+30,780$45.50+$1,400,49082,659Indirect
Feb 14, 2023Class A Common StockSSaleDisposed−17,336$83.28F1−$1,443,742.0865,323Indirect
Feb 14, 2023Class A Common StockSSaleDisposed−13,444$83.76F2−$1,126,069.4451,879Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 13, 2023Class A Common StockGGiftDisposed−98,200$0.00$00Direct
Feb 13, 2023Class A Common StockGGiftAcquired+98,200$0.00$098,200Indirect
Feb 14, 2023Class A Common StockMOption exerciseDisposed−30,780$0.00$061,559Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The shares were sold in multiple transactions at prices ranging from $82.67 to $83.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F2

The shares were sold in multiple transactions at prices ranging from $83.67 to $83.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)